ID: ALA8953

Max Phase: Preclinical

Molecular Formula: C16H16ClNO4

Molecular Weight: 321.76

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1cc(C(=O)c2cc(Cl)ccc2N)cc(OC)c1OC

Standard InChI:  InChI=1S/C16H16ClNO4/c1-20-13-6-9(7-14(21-2)16(13)22-3)15(19)11-8-10(17)4-5-12(11)18/h4-8H,18H2,1-3H3

Standard InChI Key:  XNXGUYDYCYSOCU-UHFFFAOYSA-N

Associated Targets(Human)

KB 17409 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

CPT30 cell line 7 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

HONE1 cell line 118 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

KB 3-1 1143 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

HT-29 80576 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

TSGH 45 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

T98G 1524 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Tubulin 2175 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Brain 4203 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Plasma 6361 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 321.76Molecular Weight (Monoisotopic): 321.0768AlogP: 3.18#Rotatable Bonds: 5
Polar Surface Area: 70.78Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 1.78CX LogP: 3.38CX LogD: 3.38
Aromatic Rings: 2Heavy Atoms: 22QED Weighted: 0.68Np Likeness Score: -0.35

References

1. Hsieh HP, Liou JP, Lin YT, Mahindroo N, Chang JY, Yang YN, Chern SS, Tan UK, Chang CW, Chen TW, Lin CH, Chang YY, Wang CC..  (2003)  Structure-activity and crystallographic analysis of benzophenone derivatives-the potential anticancer agents.,  13  (1): [PMID:12467626] [10.1016/s0960-894x(02)00850-8]
2. Liou JP, Chang JY, Chang CW, Chang CY, Mahindroo N, Kuo FM, Hsieh HP..  (2004)  Synthesis and structure-activity relationships of 3-aminobenzophenones as antimitotic agents.,  47  (11): [PMID:15139768] [10.1021/jm0305974]
3. Silber BM, Gever JR, Rao S, Li Z, Renslo AR, Widjaja K, Wong C, Giles K, Freyman Y, Elepano M, Irwin JJ, Jacobson MP, Prusiner SB..  (2014)  Novel compounds lowering the cellular isoform of the human prion protein in cultured human cells.,  22  (6): [PMID:24530226] [10.1016/j.bmc.2014.01.001]
4. Mark Wenlock and Nicholas Tomkinson. Experimental in vitro DMPK and physicochemical data on a set of publicly disclosed compounds,  [10.6019/CHEMBL3301361]